Clinical-stage biotechnology company Vaxxas has appointed three global vaccine experts as advisors as it progresses its ...
Health-care companies rose after strong earnings from one major drug maker. Novo Nordisk shares rose sharply after the Danish obesity-drug maker posted fourth-quarter Ozempic sales of $4.71 billion, ...
Foreign aid programs at risk of being cut by Trump and Musk represent a tiny fraction of overall federal spending.
Pfizer reported strong 2024 profits Wednesday on the same day the Connecticut Attorney General’s office released a statement ...
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
Pfizer CEO Albert Bourla told investors he dined with RFK Jr, a vaccine skeptic and nominee to head HHS. They discussed ...
Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...
MoneyShow presents top investment ideas for 2024 from leading advisors. Part 8 includes Lara Exploration, Imperial Oil, Avino ...
Container shipping liner Hapag-Lloyd will be able to cope with the advent of U.S. tariffs on Chinese products, its chief executive told reporters on Tuesday. Ciara Lee reports.
Bose, 54, promised a junior colleague more money for a 'couple of hours' work than he would make in a month if she went along ...
Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results